Sonic Gp LLC Fennec Pharmaceuticals Inc. Transaction History
Sonic Gp LLC
- $45.4 Billion
- Q4 2024
A detailed history of Sonic Gp LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Sonic Gp LLC holds 2,407,357 shares of FENC stock, worth $20.1 Million. This represents 33.54% of its overall portfolio holdings.
Number of Shares
2,407,357
Previous 2,407,357
-0.0%
Holding current value
$20.1 Million
Previous $12 Billion
26.4%
% of portfolio
33.54%
Previous 27.51%
Shares
1 transactions
Others Institutions Holding FENC
# of Institutions
70Shares Held
13.9MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$34.1 Million0.72% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$18.8 Million9.62% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$9.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA965KShares$8.07 Million0.0% of portfolio
-
Harbert Fund Advisors, Inc. Birmingham, AL467KShares$3.91 Million3.22% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $218M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...